Gaceta SanitariaPub Date : 2025-01-01DOI: 10.1016/j.gaceta.2025.102454
Irene Falgas-Bague , Helena Llonch Valsells , Maria Juan Corbella , Francisco Collazos , Andrea Fernandez-Rodriguez
{"title":"Estrategias para organizar la investigación y la atención en salud mental de poblaciones migrantes","authors":"Irene Falgas-Bague , Helena Llonch Valsells , Maria Juan Corbella , Francisco Collazos , Andrea Fernandez-Rodriguez","doi":"10.1016/j.gaceta.2025.102454","DOIUrl":"10.1016/j.gaceta.2025.102454","url":null,"abstract":"<div><div>The mental health challenges faced by the migrant population in Spain are analyzed, emphasizing the gaps of our healthcare system to addresses their specific needs. Among these challenges are a high prevalence of mental disorders, increased exposure to mental health determinants, differences in the expression of distress, and behaviors related to access and demand for services. Proposals are presented to improve healthcare at multiple levels: 1) fostering of high-impact research, 2) providing rigorous culturally humility training for healthcare professionals and for the integration of community mental health agents, and 3) establishing reference care units as an organizational shift to enhance care and promote public health policies. In conclusion, urgent action through public health policies is necessary to ensure the best care for all.</div></div>","PeriodicalId":12494,"journal":{"name":"Gaceta Sanitaria","volume":"39 ","pages":"Article 102454"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gaceta SanitariaPub Date : 2025-01-01DOI: 10.1016/j.gaceta.2025.102492
José Ramón Repullo Labrador
{"title":"Mutualismo administrativo: el debate que ya no puede seguir ignorándose","authors":"José Ramón Repullo Labrador","doi":"10.1016/j.gaceta.2025.102492","DOIUrl":"10.1016/j.gaceta.2025.102492","url":null,"abstract":"","PeriodicalId":12494,"journal":{"name":"Gaceta Sanitaria","volume":"39 ","pages":"Article 102492"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143791299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gaceta SanitariaPub Date : 2025-01-01DOI: 10.1016/j.gaceta.2025.102458
Enrique Pérez-Miguel, Sergi Trias-Llimós
{"title":"Educational inequalities in cardiovascular mortality in Spanish regions (2016-2021)","authors":"Enrique Pérez-Miguel, Sergi Trias-Llimós","doi":"10.1016/j.gaceta.2025.102458","DOIUrl":"10.1016/j.gaceta.2025.102458","url":null,"abstract":"<div><h3>Objective</h3><div>Cardiovascular diseases (CVD) are the leading cause of death in low-mortality countries, but subpopulation level differences exist. This study assesses educational inequalities in CVD mortality by sex in Spanish regions (2016-2021).</div></div><div><h3>Method</h3><div>Age-standardised mortality rates by sex, region and education were estimated using individual-level mortality data from individuals aged ≥35 years residing in Spain provided by the Spanish National Statistics Institute. The Relative and the Slope Indexes of Inequality (RII and SII) were estimated to assess educational inequalities.</div></div><div><h3>Results</h3><div>For the whole Spain, RII was 1.79 (IC95%: 1.42-2.26) for women and 1.59 (IC95%: 1.33-1.91) for men, with differences across regions. The greatest inequalities were found in the Balearic and Canary Islands, and the lowest in La Rioja.</div></div><div><h3>Conclusions</h3><div>Continued efforts monitoring and tackling cardiovascular morbidity and its determinants are needed at the national and regional level to further contribute to reducing cardiovascular mortality levels and inequalities therein.</div></div>","PeriodicalId":12494,"journal":{"name":"Gaceta Sanitaria","volume":"39 ","pages":"Article 102458"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143437529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gaceta SanitariaPub Date : 2025-01-01DOI: 10.1016/j.gaceta.2025.102470
Rafael Dal-Ré
{"title":"Ensayos clínicos no comerciales con medicamentos en España: dos problemas por solucionar","authors":"Rafael Dal-Ré","doi":"10.1016/j.gaceta.2025.102470","DOIUrl":"10.1016/j.gaceta.2025.102470","url":null,"abstract":"","PeriodicalId":12494,"journal":{"name":"Gaceta Sanitaria","volume":"39 ","pages":"Article 102470"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143578516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gaceta SanitariaPub Date : 2025-01-01DOI: 10.1016/j.gaceta.2024.102444
Celia Robles Cabanillas , Isabel Hurtado Navarro , Aníbal García-Sempere , Fran Llopis-Cardona , Francisco Sánchez-Sáez , Clara Rodríguez-Bernal , Gabriel Sanfélix-Gimeno
{"title":"Association of glucagon-like peptide-1 receptor agonists with acute pancreatitis and biliary disease in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study","authors":"Celia Robles Cabanillas , Isabel Hurtado Navarro , Aníbal García-Sempere , Fran Llopis-Cardona , Francisco Sánchez-Sáez , Clara Rodríguez-Bernal , Gabriel Sanfélix-Gimeno","doi":"10.1016/j.gaceta.2024.102444","DOIUrl":"10.1016/j.gaceta.2024.102444","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the risk of acute pancreatitis and biliary disease in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA).</div></div><div><h3>Method</h3><div>Population-based, propensity-weighted, new user, active comparator design study including patients with diabetes and obesity initiating treatment with GLP-1 RA or the comparator group sodium-glucose cotransporter 2 inhibitors (SGLT-2i) in the region of Valencia from 2015 to 2021.</div></div><div><h3>Results</h3><div>In adjusted, per protocol main analysis, no risk differences were found for acute pancreatitis (HR: 0.56; 95%CI: 0.17-1.91) nor for biliary disease (HR: 1.12; IC95%: 0.79, 1.58). Secondary analyses yielded similar results.</div></div><div><h3>Conclusions</h3><div>Despite we did not observe increased risk of gastrointestinal events in GLP-1 RA vs SGLT-2i patients, adherence to approved indications and close monitoring of potential adverse events are warranted to ensure patient safety.</div></div>","PeriodicalId":12494,"journal":{"name":"Gaceta Sanitaria","volume":"39 ","pages":"Article 102444"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gaceta SanitariaPub Date : 2025-01-01DOI: 10.1016/j.gaceta.2024.102440
Lucía Martín-Gisbert , Alberto Ruano Raviña , Marta García-Talavera , Cristina Candal-Pedreira , Guadalupe García , Leonor Varela Lema , Mónica Pérez Ríos , Julia Rey-Brandariz
{"title":"Radon mitigation in the workplace in Spain: a cross-sectional interview-based study","authors":"Lucía Martín-Gisbert , Alberto Ruano Raviña , Marta García-Talavera , Cristina Candal-Pedreira , Guadalupe García , Leonor Varela Lema , Mónica Pérez Ríos , Julia Rey-Brandariz","doi":"10.1016/j.gaceta.2024.102440","DOIUrl":"10.1016/j.gaceta.2024.102440","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate radon mitigation frequency and possible determinants for mitigation among employers in Spain, before the new regulation came into force. We also aimed to assess the reasons for not mitigating radon.</div></div><div><h3>Method</h3><div>In this cross-sectional study, participants were systematically identified from all employers in Spain who had previously measured occupational radon through the Galician Radon Laboratory from 2015 until 2022. Employers responsible for at least one workplace where radon levels exceeded 300 Bq/m<sup>3</sup> were included. Participants were interviewed via phone call by a trained interviewer. The information was recorded using an <em>ad hoc</em> questionnaire created as a result of a review. We analyzed mitigation frequency according to working sector, company size and maximum radon levels found. Reasons for not mitigating were ranked according to frequency.</div></div><div><h3>Results</h3><div>We interviewed 32 employers (response rate 91%). Overall mitigation frequency was 53%. Mitigation frequency increased with the company size. For workplaces ≥1000 Bq/m<sup>3</sup> mitigation frequency was 67%. Lack of perception of radon as a health risk was the main reason for not mitigating.</div></div><div><h3>Conclusions</h3><div>Enhancing radon mitigation frequency in the workplace is a major area of improvement. We are of the opinion that employers need guidance and availability of mitigation services to comply with the new regulatory requirements in Spain.</div></div>","PeriodicalId":12494,"journal":{"name":"Gaceta Sanitaria","volume":"39 ","pages":"Article 102440"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gaceta SanitariaPub Date : 2025-01-01DOI: 10.1016/j.gaceta.2025.102459
Aránzazu Hernández-Yumar , Yadira González-Hernández , Tasmania del Pino-Sedeño , Cristina Valcárcel-Nazco , Aythami de Armas-Castellano , Estefanía Herrera-Ramos , Julián Portero Navarro , Montserrat Carmona-Rodríguez , María Ximena Rojas-Reyes , María M. Trujillo-Martín
{"title":"Genicular artery embolization for knee osteoarthritis: a systematic review with meta-analysis and cost-analysis","authors":"Aránzazu Hernández-Yumar , Yadira González-Hernández , Tasmania del Pino-Sedeño , Cristina Valcárcel-Nazco , Aythami de Armas-Castellano , Estefanía Herrera-Ramos , Julián Portero Navarro , Montserrat Carmona-Rodríguez , María Ximena Rojas-Reyes , María M. Trujillo-Martín","doi":"10.1016/j.gaceta.2025.102459","DOIUrl":"10.1016/j.gaceta.2025.102459","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the effectiveness, safety, and cost-effectiveness of genicular artery embolization (GAE) for the treatment of mild or moderate knee osteoarthritis (KO) refractory to standard treatment, and/or severe KO in individuals not eligible for surgery.</div></div><div><h3>Method</h3><div>We conducted a systematic review with meta-analysis, supplemented by a cost-analysis, comparing GAE and standard treatment, from the perspective of the Spanish National Health System (NHS) over a one-year time horizon. The health improvement required for GAE to be deemed cost-effective was quantified, considering a willingness-to-pay threshold of 25 000 €/quality-adjusted life year (QALY).</div></div><div><h3>Results</h3><div>We included two randomized controlled trials in our analysis. Pain estimates showed inconsistent results, and no significant effects were observed for overall function, health-related quality of life, or changes in the need for pain management medication. No serious complications or major adverse events were observed. GRADE quality of evidence ranged from moderate to low. No economic evaluations were identified. Our cost-analysis revealed that GAE would result in an incremental cost of € 3432.37 per patient, requiring a health improvement of 0.137 QALY per patient to be deemed a cost-effective technology.</div></div><div><h3>Conclusions</h3><div>In summary, based on moderate to low-certainty evidence, it remains inconclusive whether there is any difference between GAE and standard treatment for KO. However, the use of GAE would increase the costs. Larger randomized controlled trials are needed to determine the effects of using GAE for chronic pain secondary to KO and, consequently, to ascertain whether this technology could potentially become cost-effective from the NHS perspective.</div></div>","PeriodicalId":12494,"journal":{"name":"Gaceta Sanitaria","volume":"39 ","pages":"Article 102459"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143420362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gaceta SanitariaPub Date : 2025-01-01DOI: 10.1016/j.gaceta.2025.102450
Alberto Lana-Pérez, María Errea, Salvador Peiró, en representación del Comité editorial de Gaceta Sanitaria
{"title":"Gaceta Sanitaria en 2024. Nuevo equipo editorial, caída del factor de impacto con subida de cuartil, incremento en los costes de publicación y otras novedades","authors":"Alberto Lana-Pérez, María Errea, Salvador Peiró, en representación del Comité editorial de Gaceta Sanitaria","doi":"10.1016/j.gaceta.2025.102450","DOIUrl":"10.1016/j.gaceta.2025.102450","url":null,"abstract":"","PeriodicalId":12494,"journal":{"name":"Gaceta Sanitaria","volume":"39 ","pages":"Article 102450"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}